Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2012 Feb;56(2):783–786. doi: 10.1128/AAC.05116-11

Evolution of IncA/C blaCMY-2-Carrying Plasmids by Acquisition of the blaNDM-1 Carbapenemase Gene

Alessandra Carattoli a, Laura Villa a, Laurent Poirel b, Rémy A Bonnin b, Patrice Nordmann b,
PMCID: PMC3264282  PMID: 22123704

Abstract

The blaNDM-1 gene has been reported to be often located on broad-host-range plasmids of the IncA/C type in clinical but also environmental bacteria recovered from the New Delhi, India, area. IncA/C-type plasmids are the main vehicles for the spread of the cephalosporinase gene blaCMY-2, frequently identified in the United States, Canada, and Europe. In this study, we completed the sequence of IncA/C plasmid pNDM-KN carrying the blaNDM-1 gene, recovered from a Klebsiella pneumoniae isolate from Kenya. This sequence was compared with those of three IncA/C-type reference plasmids from Escherichia coli, Yersinia ruckeri, and Photobacterium damselae. Comparative analysis showed that the blaNDM-1 gene was located on a widely diffused plasmid scaffold known to be responsible for the spread of blaCMY-2-like genes and consequently for resistance to broad-spectrum cephalosporins. Considering that IncA/C plasmids possess a broad host range, this scaffold might support a large-scale diffusion of the blaNDM-1 gene among Gram-negative rods.

INTRODUCTION

The blaNDM-1 gene was initially identified in Klebsiella pneumoniae and Escherichia coli isolates but has since been reported for many different enterobacterial species and also Acinetobacter baumannii (7, 1416, 19, 29, 32). Noteworthy, the blaNDM-1 gene was most often reported to be carried on plasmids in enterobacterial species, whereas it was chromosomally carried in A. baumannii (14). In particular, it has been often reported to be carried on IncA/C-type plasmids, as found for blaNDM-1-positive K. pneumoniae isolates from Switzerland (25) and Kenya (24), Proteus mirabilis isolates from Switzerland (24), and E. coli isolates from France (23). A recent study focusing on environmental water samples recovered from the New Delhi, India, area reported IncA/C-type plasmids carrying the blaNDM-1 gene in E. coli, Citrobacter freundii, and also Vibrio cholerae (32), thus emphasizing the potential of this type of plasmid to act as a vehicle for the spread of the blaNDM-1 gene.

IncA/C-type plasmids have been extensively investigated in the last 10 years, since they have been shown to be the main vehicles for the spread of blaCMY-2 cephalosporinase genes frequently identified in E. coli and Salmonella sp. isolates in the United States, Canada, and Europe (1, 2, 4, 912, 17, 18). IncA/C-type plasmids have been identified from isolates of human but also of animal origins, for example, from beef, chicken, turkey, and pork samples (34). Those plasmids possess a broad host range of replication, being identified in all enterobacterial species but also in Photobacterium damselae and Aeromonas salmonicida (33).

In this study, we completed the sequence of IncA/C plasmid pNDM-KN (formerly referred to as pKp7 [24]) carrying the blaNDM-1 gene, recovered from a K. pneumoniae isolate. That clinical isolate was recovered in November 2009 at a hospital in Nairobi, Kenya. In addition to the blaNDM-1 gene, this isolate carried supplementary resistance genes, including the extended-spectrum-β-lactamase (ESBL) genes blaSHV-28 and blaCTX-M-15 together with the AmpC gene blaCMY-6 and the class D narrow-spectrum β-lactamase genes blaOXA-1 and blaOXA-9. It also carried the rmtC 16S RNA methylase gene conferring high-level resistance to all aminoglycosides.

A comparative analysis of the sequence of plasmid pNDM-KN with the sequences of other plasmids belonging to the IncA/C family demonstrated the evolutionary relationship between this blaNDM-1-bearing plasmid and the IncA/C plasmids carrying blaCMY-2, suggesting a recent acquisition of the blaNDM-1 gene by this successful plasmid type.

MATERIALS AND METHODS

Whole-plasmid sequencing.

Plasmid pNDM-KN was characterized previously (24). To obtain the DNA sequence, plasmid DNA was purified by using the Qiaquick kit (Qiagen, Courtaboeuf, France) according to the manufacturer's protocol. The complete sequencing work flow of the Illumina Genome Analyzer IIx system was performed by the DNAVision Company (Gosselles, Belgium). A single contiguous sequence with at least 15-fold coverage was obtained for plasmid pNDM-KN using draft assembly and PCR-based gap closure.

Bioinformatics.

Open reading frames were predicted and annotated by using DNAMAN 5.2.10 software (Lynnon BioSoft; Lynnon Corporation). Each predicted protein was compared against an all-protein database by using BlastP (http://blast.ncbi.nlm.nih.gov/Blast.cgi), with a minimum cutoff of 30% identity and over 80% length coverage. Gene sequences were further compared and aligned with GenBank data by using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and CLUSTAL W (http://www.ebi.ac.uk/clustalw). IncA/C plasmids pAR060302 from E. coli (GenBank accession no. FJ621588), pYR1 from Y. ruckeri (GenBank accession no. CP000602), and pP91278 from P. damselae (GenBank accession no. AB277724) were used as references for annotating pNDM-KN.

Nucleotide sequence accession number.

The GenBank accession number for plasmid pNDM-KN is JN157804.

RESULTS AND DISCUSSION

Comparison of plasmid pNDM-KN and other IncA/C plasmids.

A BLAST analysis of the completed nucleotide sequence of plasmid pNDM-KN performed in comparison with the reference IncA/C-type plasmids pAR060302 from E. coli (4), pYR1 from Y. ruckeri, and pP91278 from P. damselae showed that pNDM-KN is an IncA/C plasmid with a backbone similar to those of other IncA/C plasmids (>99% nucleotide sequence identity), with the exception of four major regions of discontinuity (Fig. 1).

Fig 1.

Fig 1

Major structural features of pNDM-KN in comparison with IncA/C plasmids pAR060302 (GenBank accession no. FJ621588), pYR1 (GenBank accession no. CP000602), and pP91278 (GenBank accession no. AB277724). White boxes indicated plasmid scaffold regions that are in common among plasmids. The tra locus is indicated within the boxes. Resistance genes are indicated by orange boxes, except for the blaNDM-1 gene, which is indicated by a blue box. Transposon-related genes (tnpA, tnpR, and tnpM) and insertion sequences are indicated by red boxes. Other genes are indicated by boxes colored as follows: violet, the replicase gene repA; gray, restriction enzyme and DNA methylase genes; green, the groEL-groES cluster; pale blue, the sugE and bcl genes; brown, the blaCMY genes. hyp, hypothetical.

(i) The phage integrase-rhs regions as hot spot for integration.

The sequence of plasmid pNDM-KN shows the acquisition of a novel type I site-specific restriction-modification system of the HsdR type that includes genes encoding a DNase, a restriction enzyme, and a related ATP-dependent DNA helicase (Fig. 1). The best BLAST hit for this novel type I restriction system was with that identified in the genome of Xanthomonas campestris pv. vesicatoria (>84% nucleotide sequence identity; GenBank accession no. AM039952). This HsdR operon was inserted into the gene encoding a site-specific recombinase of phage origin, being a common feature of all IncA/C plasmid scaffolds (Fig. 1), and was flanked by a Tn7-like transposon. The Tn7-like transposition occurred within the rhs gene that is also a common feature of IncA/C plasmids. The region encompassing the phage-integrase and the rhs genes is likely a hot spot for the integration of accessory genes within IncA/C plasmids.

(ii) Evolution of the blaNDM-1 locus.

The mer operon of pAR060302 is part of a complex hybrid transposon inserted into the IncA/C backbone flanked by direct repeats, and related structures are found in other IncA/C plasmids. The strA-strB genes in pYR1 are part of a Tn5393 that was recently described (3, 4). The synteny among the compared plasmids restarted at the DNA primase gene (Fig. 1). IncA/C plasmid pP91278 from P. damselae likely represents the IncA/C scaffold before the acquisition of the accessory genes, since it does not show any insertion between the phage-integrase, rhs, and DNA primase genes (Fig. 1).

An analysis of the pNDM-KN sequence revealed that the rhs gene was deleted at its 3′ and 5′ extremities and was adjacent to the heat shock chaperone groEL-groES cluster (28). In pAR060302, this cluster flanked a class 1 integron that contained the aac(3)-IVa and aadA1 gene cassettes, but it was absent in plasmids pYR1 and pP91278 (Fig. 1). Analysis of the sequences located at the right extremity of the blaNDM-1 locus on plasmid pNDM-KN revealed the presence of a class 1 integron structure bearing the cmlA7 (chloramphenicol resistance), aadA1 (streptomycin resistance), ereC (erythromycin resistance), and arr2 (rifampin resistance) gene cassettes. This integron was previously described for an NDM-1-producing K. pneumoniae strain from a Swedish patient of Indian origin (35). The similarity between these two plasmids continues through the intI1 integrase gene and the Tn1696 resolvase and transposase genes. However, the integron identified in plasmid pAR060302 was associated with an ISCR16 element, which was not detected in plasmid pNDM-KN (30).

A detailed analysis of the immediate genetic environment surrounding the blaNDM-1 gene (considering those present on pNDM-KN and absent on pAR060302) revealed novel features. As previously described for other blaNDM-1-carrying plasmids, upstream of the blaNDM-1 gene, part of ISAba125 was identified (our unpublished data). This insertion sequence, which provides the −35 promoter region for blaNDM-1 expression, was truncated by the insertion of ISKpn14 (previously identified in K. pneumoniae). However, no remnant of ISAba125 was identified on the other extremity of ISKpn14. Instead, a truncated fragment of ISEcp1 was identified, followed by the 16S rRNA methylase rmtC gene. This association between ISEcp1 and rmtC was previously described (31). Genes encoding a type III endonuclease and a methyltransferase were then identified, with both sharing sequence similarities with genes from the X. campestris genome, which, however, are not colinear, as they appear on plasmid pNDM-KN (>84% nucleotide sequence identity; GenBank accession no. AM039952). Downstream of the blaNDM-1 gene, the bleMBL (bleomycin resistance associated with metallo-β-lactamase [MBL]) gene, encoding a putative protein conferring resistance to bleomycin, was identified, as found previously for other blaNDM-1-bearing plasmids (21, 23).

According to this in silico analysis, it was not possible to determine the genetic events that led to the formation of this heterogeneous genetic structure. However, it is likely that independent and multiple genetic events contributed to the acquisition of the blaNDM-1- and rmtC-containing locus.

(iii) The ISEcp1-blaCMY module region.

In IncA/C plasmids, one or more copies of the ISEcp1-blaCMY transposition unit gene are inserted within the Tra region in a module that also contains the blc and sugE genes (4, 22, 27). The ISEcp1-blaCMY-6 (CMY-6 differs just in the W661→L amino acid substitution from CMY-2) module was found to be inserted in the same position into the Tra region of plasmid pNDM-KN but with an ISEc23 inserted into the sugE gene. The insertion of the ISEcp1-blaCMY module within the Tra locus was demonstrated previously to significantly reduce the conjugation frequency of IncA/C plasmids compared to those that do not carry this module (27). The presence of this very well conserved region showed plasmid pNDM-KN was an IncA/C blaCMY-carrying plasmid that has acquired the blaNDM-1 gene within its scaffold as a secondary event.

(iv) The parA-parB gene region.

The remaining part of plasmid pNDM-KN was similar to the corresponding region of plasmid pYR1 from Y. ruckeri, including the korB, parB, and parA and genes, encoding the putative restriction methyltransferase and DNA methylases. In this region, plasmids pAR060302 and pP91278 carried other resistance genes integrated between the parA and parB genes (sul2, strA, strB, dhfr, and tetA-tetR of the A and D types, respectively) (Fig. 1).

Conclusion.

Epidemiological studies focusing on the blaCMY-carrying IncA/C plasmids showed that these plasmids possess a high capacity for diffusion and spread, as they have been detected worldwide. They have been reported extensively for Salmonella strains of animal origins (6, 34). According to the most recent studies that have been conducted, these plasmids likely play an important role in the rapid and efficient dissemination of the blaNDM-1 gene in several bacterial species from both human cases and the environment. In particular, these plasmids, which are known to be of broad host range, have been detected in numerous multidrug-resistant Gram-negative species isolated from India and the United Kingdom and from water samples from New Delhi (32).

Interestingly, a study performed on commensal and pathogenic E. coli isolates that did not consider antimicrobial resistance as a criterion of selection revealed that the RepA/C replicon occurred in only 1% of E. coli strains obtained from healthy humans not exposed to antimicrobials from United States and was absent from the fecal flora of healthy animals (13). Therefore, the rate of occurrence of IncA/C plasmids in nonresistant bacterial populations is not high, and these plasmids are probably advantaged in populations that are under antimicrobial selective pressure (34).

The blaNDM-1 gene is not the first carbapenemase gene that has been identified on an IncA/C scaffold, since IncA/C-type plasmids carrying the blaVIM-4 gene have been identified in K. pneumoniae and Enterobacter cloacae clinical isolates in Italy (5, 8, 12). IncA/C-IncP multireplicon plasmids carrying the blaIMP-13 gene were also identified in Salmonella isolates from food sources in Colombia (20). Apart from carbapenemase genes, it was also demonstrated previously that IncA/C-type plasmids were at the origin of the worldwide spread of the ESBL gene blaVEB-1 (often associated to the quinolone resistance gene qnrA1) in members of the Enterobacteriaceae (26).

We report here the whole sequence of an IncA/C-type plasmid carrying the blaNDM-1 gene identified in a K. pneumoniae clinical isolate from Kenya. The acquisition of this emerging MBL resistance gene occurred on a widely diffused plasmid scaffold known to be responsible for the spread of blaCMY-2-like genes. Considering that IncA/C plasmids possess a broad host range, this scaffold might enhance the large-scale diffusion of the blaNDM-1 gene among Gram-negative organisms.

ACKNOWLEDGMENTS

This work was partially financed by grants from the Italian Ministry of Health and the Istituto Superiore di Sanità and by a grant from the INSERM (U914).

Footnotes

Published ahead of print 28 November 2011

REFERENCES

  • 1. Baudry PJ, Mataseje L, Zhanel GG, Hoban DJ, Mulvey MR. 2009. Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units. Diagn. Microbiol. Infect. Dis. 65: 379–383 [DOI] [PubMed] [Google Scholar]
  • 2. Blanc V, et al. 2008. Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms. Int. J. Antimicrob. Agents 31: 76–78 [DOI] [PubMed] [Google Scholar]
  • 3. Cain AK, Hall R. 2011. Transposon Tn5393e carrying the aphA1-containing transposon Tn6023 upstream of strAB does not confer resistance to streptomycin. Microb. Drug Resist. 17: 389–394 [DOI] [PubMed] [Google Scholar]
  • 4. Call DR, et al. 2010. blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54: 590–596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Carattoli A, et al. 2006. Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg. Infect. Dis. 12: 1145–1148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Carattoli A, et al. 2002. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46: 1269–1272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chen Y, Zhou Z, Jiang Y, Yu Y. 2011. Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66: 1255–1259 [DOI] [PubMed] [Google Scholar]
  • 8. Colinon C, Miriagou V, Carattoli A, Luzzaro F, Rossolini GM. 2007. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamases. J. Antimicrob. Chemother. 60: 258–262 [DOI] [PubMed] [Google Scholar]
  • 9. Daniels JB, Call DR, Besser TE. 2007. Molecular epidemiology of blaCMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest. Appl. Environ. Microbiol. 73: 8005–8011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Dunne EF, et al. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284: 3151–3156 [DOI] [PubMed] [Google Scholar]
  • 11. Folster JP, et al. 2010. Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from humans in the United States. Foodborne Pathog. Dis. 7: 181–187 [DOI] [PubMed] [Google Scholar]
  • 12. Hopkins KL, et al. 2006. Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 50: 3203–3206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Johnson TJ, et al. 2007. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl. Environ. Microbiol. 73: 1976–1983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kaase M, et al. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66: 1260–1262 [DOI] [PubMed] [Google Scholar]
  • 15. Karthikeyan K, Thirunarayan MA, Krishnan P. 2010. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65: 2253–2254 [DOI] [PubMed] [Google Scholar]
  • 16. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10: 597–602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Lindsey RL, Fedorka-Cray PJ, Frye JG, Meinersmann RJ. 2009. Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates. Appl. Environ. Microbiol. 75: 1908–1915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Mataseje LF, et al. 2010. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn. Microbiol. Infect. Dis. 67: 387–391 [DOI] [PubMed] [Google Scholar]
  • 19. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 66: 689–692 [DOI] [PubMed] [Google Scholar]
  • 20. O'Mahoni R, et al. 2006. Antimicrobial resistance in nontyphoidal Salmonella from food sources in Colombia: evidence for an unusual plasmid-localized class 1 integron in serotypes Typhimurium and Anatum. Microb. Drug Resist. 12: 269–277 [DOI] [PubMed] [Google Scholar]
  • 21. Poirel L, Bonnin RA, Nordmann P. 2011. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob. Agents Chemother. 55: 4224–4229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Poirel L, Decousser J-W, Nordmann P. 2003. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob. Agents Chemother. 47: 2938–2945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Poirel L, Dortet L, Bernabeu S, Nordmann P. 22 August 2011. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. doi:10.1128/AAC.00585-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Poirel L, Revathi G, Bernabeu S, Nordmann P. 2011. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55: 934–936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Poirel L, et al. 2011. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J. Antimicrob. Chemother. 66: 1730–1733 [DOI] [PubMed] [Google Scholar]
  • 26. Poirel L, et al. 2007. Expanded-spectrum β-lactamase and plasmid-mediated quinolone resistance. Emerg. Infect. Dis. 13: 803–805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Poole TL, et al. 2009. Conjugative transferability of the A/C2 plasmid from Salmonella enterica blaCMY-2 producers and non-producers. Foodborne Pathog. Dis. 6: 1185–1194 [DOI] [PubMed] [Google Scholar]
  • 28. Rye HS, et al. 1999. GroEL-GroES cycling: ATP and non-native polypeptide direct alternation of folding-active rings. Cell 97: 325–338 [DOI] [PubMed] [Google Scholar]
  • 29. Sidjabat H, et al. 2011. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase. Clin. Infect. Dis. 15: 481–484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Toleman MA, Walsh TR. 2010. ISCR elements are key players in IncA/C plasmid evolution. Antimicrob. Agents Chemother. 54: 3534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Wachino J, et al. 2006. Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a Proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides. Antimicrob. Agents Chemother. 50: 178–184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11: 355–362 [DOI] [PubMed] [Google Scholar]
  • 33. Welch TJ, et al. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2: e309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. 2001. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45: 2716–2722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Yong D, et al. 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53: 5046–5054 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES